Sensei Biotherapeutics Inc.
13F holders, Q1 2025 (March 31)19holders −5
2new positions
7sold out
1famous investor
$0.39avg. 13F price*
At the end of Q1 2025, 19 institutions reported holding Sensei Biotherapeutics Inc. in their 13F filings, down 5 from Q4 2024. 2 opened new positions and 7 sold out. The largest holders were Vanguard Group Inc. ($231K), Ikarian Capital, LLC ($177K) and Catalio Capital Management, LP ($116K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Sensei Biotherapeutics Inc.
- CUSIP
- 81728A108
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1K |
| Exits | 7 | $120K |
All 13F filers, Q4 2024 → Q1 2025: 67,570 shares bought and 518,750 shares sold, net −451,180 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Vanguard Group Inc. | 0.00% | Reduce -1.5% | 585,576 | $231K |
| Ikarian Capital, LLC | 0.06% | Reduce -30.8% | 449,963 | $177K |
| Catalio Capital Management, LP | 0.03% | No change | 294,374 | $116K |
| Renaissance Technologies | 0.00% | Add +13.1% | 177,300 | $70K |
| Geode Capital Management, LLC | 0.00% | Add +1.2% | 150,709 | $59K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -37.1% | 108,658 | $43K |
| UBS Group AG | 0.00% | Add +2126950.0% | 42,541 | $17K |
| Northern Trust Corp. | 0.00% | No change | 25,983 | $10K |
| State Street Corp. | 0.00% | No change | 25,774 | $10K |
| Cresset Asset Management, LLC | 0.00% | No change | 19,671 | $8K |
| Raymond James Financial Inc. | 0.00% | No change | 14,000 | $6K |
| Morgan Stanley | 0.00% | No change | 9,219 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.8% | 5,404 | $2K |
| Barclays PLC | 0.00% | New | 2,558 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -0.4% | 702 | $276 |
| BNP Paribas Financial Markets | 0.00% | No change | 160 | $63 |
| Bank of America Corp. | 0.00% | Add +4.4% | 142 | $56 |
| Citigroup Inc. | 0.00% | New | 124 | $49 |
| SBI Securities Co., Ltd. | 0.00% | Add +29.6% | 92 | $36 |
"% of holder's portfolio" is SENSEI BIOTHERAPEUTICS INC's weight in each manager's 13F, not the share of Sensei Biotherapeutics Inc. the manager owns.